Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Neurobiol Aging. 2020 Oct 31;100:119.e7–119.e13. doi: 10.1016/j.neurobiolaging.2020.10.019

Table 1:

SKAT-O and burden analysis results for each gene, across cohort and coverage depth for mutation type

Depth of coverage Gene Number of Variants Tested All rare Number of Variants Tested Rare CADD Number of Variants Tested Rare functional Number of Variants Tested Rare nonsynonymous Number of Variants Tested Rare loss-of-function
SKAT-O SKAT Burden SKAT-O SKAT Burden SKAT-O SKAT Burden SKAT-O SKAT Burden SKAT-O SKAT Burden
30x McGill
DNAJC13 143 0.727 0.494 37 0.905 1 47 0.845 0.647 44 0.899 0.800 NV NV NV
EIF4G1 56 0.733 0.818 16 0.637 0.986 38 0.566 0.836 23 0.872 0.690 8 0.315 1
GIGYF2 164 0.254 0.236 19 0.237 0.477 48 0.104 0.075 24 0.320 0.659 9 0.885 0.854
HTRA2 13 0.592 0.341 3 0.798 0.798 7 0.292 0.513 2 0.223 0.223 1 0.611 0.611
UCHL1 26 0.827 1 2 0.729 0.341 12 0.502 1 4 0.480 0.313 NV NV NV
Columbia
DNAJC13 97 0.709 0.493 28 0.344 0.206 32 0.500 0.317 31 0.594 0.393 NV NV NV
EIF4G1 47 0.511 0.341 13 0.983 0.862 26 0.384 0.239 17 0.634 0.429 5 0.406 0.759
GIGYF2 118 0.783 0.576 11 0.638 0.555 36 0.793 0.640 15 0.889 0.758 6 0.555 0.584
HTRA2 10 0.276 0.323 2 0.344 0.774 6 0.835 0.835 2 0.344 0.774 NV NV NV
UCHL1 19 0.751 0.715 3 0.928 0.771 9 0.891 0.741 3 0.781 0.547 NV NV NV
Sheba
DNAJC13 60 0.042 0.569 21 0.002 0.264 24 0.001 0.152 23 0.001 0.117 NV NV NV
EIF4G1 34 0.703 0.489 14 0.544 0.678 18 0.617 0.583 13 0.635 0.688 2 0.103 0.103
GIGYF2 88 0.278 0.203 8 0.837 0.709 35 0.198 0.232 8 0.654 0.473 14 0.165 0.159
HTRA2 7 0.066 0.080 3 0.046 0.046 6 0.264 0.138 3 0.046 0.046 NV NV NV
UCHL1 6 0.479 0.344 1 0.845 0.845 5 0.574 0.335 2 0.918 0.795 NV NV NV
Merged
DNAJC13 219 0.003 0.644 64 0.039 0.076 79 0.006 0.007 75 0.011 0.015 NV NV NV
EIF4G1 104 0.669 0.850 31 0.035 0.172 62 0.365 0.239 42 0.238 0.712 7 0.208 0.150
GIGYF2 284 0.246 0.787 32 0.634 0.449 94 0.322 0.418 38 0.682 0.840 24 0.310 0.302
HTRA2 24 0.917 0.953 7 0.869 0.579 18 0.728 0.975 6 0.844 0.844 1 0.700 0.700
UCHL1 39 0.406 0.817 5 0.429 0.376 18 0.601 1 6 0.181 0.280 NV NV NV
50x McGill
DNAJC13 82 0.602 0.544 23 0.399 1 28 0.410 0.833 25 0.416 0.860 NV NV NV
EIF4G1 13 0.438 1 2 0.864 0.864 11 0.299 1 3 0.945 0.834 5 0.241 0.870
GIGYF2 103 0.331 0.351 15 0.129 1 37 0.093 0.136 20 0.163 0.800 3 0.845 0.845
HTRA2 NV NV NV NV NV NV NV NV NV NV NV NV NV NV NV
UCHL1 17 0.435 0.288 2 0.715 0.715 4 0.282 0.193 4 0.282 0.193 NV NV NV
Columbia
DNAJC13 66 0.619 0.411 19 0.359 0.218 22 0.386 0.236 21 0.502 0.322 NV NV NV
EIF4G1 7 0.568 0.590 NV NV NV 3 0.329 0.989 NV NV NV 1 0.331 0.331
GIGYF2 70 0.370 0.228 9 0.453 0.264 25 0.308 0.181 11 0.618 0.434 2 0.202 0.135
HTRA2 NV NV NV NV NV NV NV NV NV NV NV NV NV NV NV
UCHL1 14 0.525 0.694 3 0.468 0.378 3 0.695 0.922 3 0.695 0.922 NV NV NV
Sheba
DNAJC13 38 0.043 0.151 14 2×10−4 0.132 15 5*10−4 0.139 14 2×10−4 0.132 NV NV NV
EIF4G1 2 0.615 0.369 1 0.754 0.754 1 0.754 0.754 1 0.754 0.754 NV NV NV
GIGYF2 40 0.626 0.416 5 0.607 0.444 19 0.510 0.335 7 0.780 0.608 NV NV NV
HTRA2 NV NV NV NV NV NV NV NV NV NV NV NV NV NV NV
UCHL1 4 0.546 0.395 1 0.847 0.847 2 0.917 0.792 2 0.917 0.792 NV NV NV
Merged
DNAJC13 146 0.018 0.561 42 0.154 0.128 52 0.078 0.053 48 0.099 0.072 NV NV NV
EIF4G1 20 0.540 0.653 3 0.931 0.758 14 0.453 0.580 4 0.970 0.831 5 0.383 0.755
GIGYF2 164 0.033 0.276 26 0.614 0.432 64 0.886 0.701 33 0.779 0.593 5 0.735 0.584
HTRA2 NV NV NV NV NV NV NV NV NV NV NV NV NV NV NV
UCHL1 26 0.009 0.412 4 0.067 0.087 6 0.015 0.512 6 0.015 0.512 NV NV NV

Abbreviations: SKAT: Sequence Kernel Association Test; SKAT-O: Optimized Sequence Kernel Association Test; CADD: Combined Annotation Dependent Depletion; NV: No Variant